Ingredient or product comparison
Can You Take GHK-Cu Orally: Administration Route Comparison
The following table compares oral, subcutaneous, and topical GHK-Cu administration across key pharmacokinetic and practical parameters. Understanding these differences is essential for selecting the appropriate delivery method based on research objectives. Ora
This source-based comparison does not add ratings or recommend a winner.
- The following table compares oral, subcutaneous, and topical GHK-Cu administration across key pharmacokinetic and practical parameters. Understanding these differences is essential for selecting the appropriate delivery method based on research objectives.
- Oral (capsule/tablet)
- <10%
- Gastric acid hydrolysis, intestinal peptidases, hepatic first-pass metabolism
- 60–120 minutes (if detectable)
- Poor for systemic studies; unreliable for dermal studies
- Least efficient route for intact GHK-Cu delivery. High variability, low reproducibility
- Subcutaneous injection
- 70–95%
- Circulating peptidases (slower degradation)
- 30–90 minutes
- Excellent for systemic circulation studies; moderate for localized dermal studies
- Most reliable route for achieving measurable plasma levels and reproducible dosing
- Topical (formulated cream/serum)
- <5% systemic; high dermal concentration
- Stratum corneum barrier, enzymatic degradation in skin layers
- Minimal systemic exposure; dermal depot effect within 15–60 minutes
- Excellent for localized dermal and epidermal studies
- Optimal for wound healing, collagen synthesis, and localized tissue remodeling research